Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investmen ...
Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...
The global market is estimated at USD 25,900.5 million in 2025 and is forecast to reach USD 64,187.5 million by 2035, ...
ServerDomes is partnering with Global Green Generation, a global engineering and construction management organization ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
The bank’s ‘Today, Tomorrow, Forever’ framework helps families organise and navigate their wealth across three interconnected ...
The NBDL represents a transition from observing nature as something external to something that is molecularly intimate.
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
5don MSN
Star Trek: What is subspace?
The lore of subspace dates back to the very earliest years of "Star Trek." But what does this concept mean, and how is it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback